[go: up one dir, main page]

Li et al., 1996 - Google Patents

Effects of phospholipid chain length, concentration, charge, and vesicle size on pulmonary insulin absorption

Li et al., 1996

Document ID
3095184918087638334
Author
Li Y
Mitra A
Publication year
Publication venue
Pharmaceutical research

External Links

Snippet

Purpose. Non drug loaded lipid vesicles have been investigated as promoters of pulmonary insulin absorption. Methods. Physical mixtures of liposomes with insulin were delivered intratracheally to rats by direct instillation method at an insulin dose level of 1 U/kg. Results …
Continue reading at link.springer.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00—Cosmetic or similar toilet preparations
    • A61K8/02—Cosmetic or similar toilet preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles

Similar Documents

Publication Publication Date Title
Li et al. Effects of phospholipid chain length, concentration, charge, and vesicle size on pulmonary insulin absorption
US6610321B2 (en) Emulsion formulations for hydrophilic active agents
Niven et al. Nebulization of liposomes. I. Effects of lipid composition
CA1287581C (en) Liposome composition
Finkelstein et al. Enzyme replacement via liposomes variations in lipid composition determine liposomal integrity in biological fluids
CA2181390C (en) Phospholipid formulations
US5077057A (en) Preparation of liposome and lipid complex compositions
Liu et al. Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes
CA1315678C (en) Alpha-tocopherol based vesicles
CA1262334A (en) Steroidal liposomes
US5277914A (en) Preparation of liposome and lipid complex compositions
US6514523B1 (en) Carrier particles for drug delivery and process for preparation
CA2266622C (en) Hyaluronic drug delivery system
EP1021167B1 (en) High and low load formulations of igf-i in multivesicular liposomes
EP2133097A1 (en) Transpulmonary liposome for controlling drug arrival
FI102724B (en) Process for the preparation of a complex consisting of a biologically active substance and a lipid
Darwis et al. Nebulisation of rehydrated freeze-dried beclomethasone dipropionate liposomes
EP0195809A1 (en) A liposomal sustained-release aerosol delivery system
EP0467954A1 (en) PREPARATION OF COMPLEX COMPOSITIONS OF LIPOSOMES AND LIPIDS.
JP3850468B2 (en) Liposomal formulation of erythropoietin
JPH06345663A (en) Liposome preparation containing vancomycin
JPH10316555A (en) Polymer compound-containing liposome external preparation
Hernández et al. Interaction between human serum albumin and liposomes: a monolayer and liposome study
JPH10236946A (en) Improved production of double liposome formulations
YOSHIOKA Chloride leakage measurement for the evaluation of the plasma-induced instability of liposomal membrane